Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news


News in brief

AGC to open intermediate & API plant in Japan


AGC is to open an API and intermediate production plant in Japan to meet increased demand from the aging population.

Japan-based AGC is investing JPY3.7bn ($48m) in the 28,400 sq m manufacturing site to ramp up its active pharmaceutical ingredient (API) and intermediate business. The facility is due to open in a year and help sales at the business unit hit JPY15bn by 2014.


AGC is using its chemical technology to provide fluorinated compounds and is now adding a fourth API and intermediate plant to meet the expected growth in demand.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...